Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK)
inhibitor that was approved by the FDA for the treatment of renal cell ...
SUTENT® (sunitinib malate) for treatment of advanced renal cell carcinoma,
gastrointestinal stromal tumors & advanced pancreatic NET. Risk info for
Sunitinib may cause serious or life-threatening damage to the liver. Tell your
doctor if you have or have ever had liver disease or problems with your liver.
Learn about the prescription medication Sutent (Sunitinib Malate), drug uses,
dosage, side effects, drug interactions, warnings, reviews and patient labeling.
Find out more about sunitinib (also called Sutent®), which may be used to treat a
type of kidney cancer called renal cell carcinoma (RCC), gastrointestinal ...
Sunitinib inhibits cellular signaling by targeting multiple RTKs. These include all
platelet-derived growth factor receptors (PDGF-R) and vascular endothelial ...
Oct 5, 2006 ... This page contains brief information about sunitinib malate and a collection of
links to more information about the use of this drug, research ...
Easy to read patient leaflet for sunitinib. Includes indications, proper use, special
instructions, precautions, and possible side effects.
Sunitinib can cause severe or fatal effects on your liver. You will need frequent
blood tests to check your liver function during treatment. Call your doctor if you ...
Professional guide for Sunitinib Malate. Includes: pharmacology,
pharmacokinetics, contraindications, interactions, adverse reactions and more.